Disulfiram loaded calcium phosphate nanoparticles for enhanced cancer immunotherapy

Safety, Activity, and Immune Correlates of Anti–PD-1 Antibody in Cancer

Suzanne L. Topalian, F. Stephen Hodi, Julie R. Brahmer et al. · New England Journal of Medicine · 2012 · 12.7K citations · Full text

Life Sciences, Immunology, Oncology +17

Pembrolizumab plus Chemotherapy in Metastatic Non–Small-Cell Lung Cancer

Leena Gandhi, Delvys Rodríguez‐Abreu, Shirish M. Gadgeel et al. · New England Journal of Medicine · 2018 · 6.6K citations · Full text

Medicine, Oncology, Pharmacology +16

Pembrolizumab versus chemotherapy for previously untreated, PD-L1-expressing, locally advanced or metastatic non-small-cell lung cancer (KEYNOTE-042): a randomised, open-label, controlled, phase 3 trial

Tony Mok, Yi‐Long Wu, Iveta Kudaba et al. · The Lancet · 2019 · 3.3K citations · Full text

Medicine, Oncology, Pharmacology +15

The commensal microbiome is associated with anti–PD-1 efficacy in metastatic melanoma patients

Vyara Matson, Jessica Fessler, Riyue Bao et al. · Science · 2018 · 3K citations

Life Sciences, Immunology, Oncology +17

TGFβ drives immune evasion in genetically reconstituted colon cancer metastasis

Daniele V. F. Tauriello, Sergio Palomo‐Ponce, Diana Stork et al. · Nature · 2018 · 1.8K citations

Medicine, Cancer Biology, Oncology +14